Senior Director, Global Commercial Lead-Multiple Myeloma
Johnson & Johnson
- Location
- Raritan, New Jersey, United States of America
- Work model
- On-Site
- Level
- Staff
- H-1B history
- 2 approvals (FY2023)
- Posted
- Aug 25, 2026
About this role
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Marketing Job Sub Function: Strategic Marketing Job Category: People Leader All Job Posting Locations: Raritan, New Jersey, United States of America Job Description: Johnson & Johnson is recruiting for a Senior Director, Global Commercial Lead-Multiple Myeloma to be located in Raritan, NJ. About Innovative Medicine Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine The Senior Director, Global Commercial Lead-MM will report directly to the Vice President of Global Multiple Myeloma Commercial Strategy and will lead a cross-functional, highly matrixed global commercial team across both bispecific antibody brands consisting of functions including Strategic Marketing, Market Research, Global Commercial Insights and Analytics, Market Access and Pricing, Medical Affairs, Health Economics, Regulatory, Data Sciences and Regional Commercial, to develop and implement the global commercial strategy. This leader will also be responsible for crafting global launches for MM brands as well as lifecycle management for future indications and evidence generation needs. He/ she is responsible for commercial leadership on the compound development team (CDT) and global labeling teams. The Commercial Leader, Multiple Myeloma, contributes to optimizing the value in collaboration with key functions across the Global Commercial Strategy Organization (GCSO), JNJ Research and Development (R&D) and Janssen (J&JIM) business regions. Responsibilities include, but are not limited to the following: Commercial Strategy Lead the Global Commercial Team (GCT) across both brands with representation from NA, EMEA, AP, LA and other key stakeholders to develop and execute global commercial and brand strategy. Drive development of key components of commercial strategy, including brand development, public relations, medical strategy, market access/reimbursement strategies, and other market preparation programs across both brands. Build strategies and innovative go-to market approaches across both brands for flawless launch and seamless customer experience in partnership with regional operating companies. Collaborate with regional partners to lead the creation and execution of well-coordinated commercial strategies and launch plans across both brands, embedding external customer insights from patients, health care providers, pathology/testing labs and payers. Embed an increasingly digital/omnichannel mindset in our go to market models. Effectively partner with R&D and Regions to coordinate commercial plans across both brands with operational strategy as well as key holistic brand messaging. Product Development and Lifecycle Effectively partner with R&D in Compound Development Teams and within the Disease Area Strategy forums, and the regional leadership to provide input into